Background: The relation between chronic musculoskeletal pain and joint hypermobility in a small percentage of the pediatric population is well described. However, literature discussing the treatment of chronic pain associated with joint hypermobility in pediatrics is limited. The present study examines the impact of interdisciplinary treatment on chronic pain in pediatrics with joint hypermobility syndrome. Objective: To determine if pediatric patients with chronic pain related to joint hypermobility can be effectively treated with an intensive, interdisciplinary pain management program, as measured by changes in pain, psychosocial and physical functioning, as well as parental coping. Design: Retrospective cohort study. Setting: Urban academic tertiary intensive outpatient interdisciplinary pain management clinic. Participants: The study involved 30 patients who met the criteria for a diagnosis of joint hypermobility and chronic pain and completed an interdisciplinary pain management program. Intervention: All patients were treated in an intensive pediatric interdisciplinary pain management program for a duration of 6 to 8 weeks. The program provided physical therapy, occupational therapy, psychological counseling, and weekly pediatric rehabilitation medicine follow-up. Main Outcome Measures: Outcome measures included numeric rating scale pain scores, the Bath Adolescent Pain Questionnaire, and the Bath Adolescent Pain-Parent Impact Questionnaire. Changes from pre-to post-treatment were analyzed using paired-samples t tests. Results: Patients endorsed pre-to post-treatment improvements in pain, depression, general anxiety, pain-related anxiety, social functioning, and physical functioning (P < .05). The patients' parents showed significant improvements in depression, anxiety, catastrophic thinking, self-blame and helplessness, leisure functioning, and parental behavior (P < .05). Conclusion: The present findings suggest that an intensive interdisciplinary rehabilitation pain management program yields shortterm improvements in pain, emotional and physical function, and daily activity in a pediatric population diagnosed with joint hypermobility. Parents also experienced benefits from the program. A larger prospective study with longer-term follow-up is needed. Level of Evidence: III
Introduction
The relationship between chronic musculoskeletal pain and joint hypermobility in a small percentage of the pediatric population is well described [1] [2] [3] [4] [5] . The prevalence of hypermobility as reported in the literature is as high as 30%, albeit those with painful joints represent a much smaller subgroup [1] . This smaller subset of patients with pain represents a group that often presents with significant functional impairments, including problems with activities of daily living, school attendance, and sports participation. Patients also often voice a wide range of complaints, including abdominal pain, orthostatic symptoms, myofascial pain, and psychosocial problems [6] . Previous terminology describing these diagnoses included benign joint hypermobility syndrome (JHS) and EhlersDanlos syndrome (EDS) III, hypermobility type (hEDS) [7] . Recent articles propose a framework for an updated classification of joint hypermobility and specifically for diagnosing Ehlers-Danlos syndromes [8] . This includes new, proposed criteria for identifying individuals with hEDS. An updated nosology proposed by Castori et al describes a spectrum of related phenotypic disorders, including generalized joint hypermobility, hypermobility spectrum disorders, and hEDS [9] . Because of the updated nosology as proposed by Castori et al, those patients that we labeled as having JHS would likely be diagnosed as having hypermobility spectrum disorder. As a result of the nature of this retrospective study, patients labeled with EDS may or may not have met the new criteria for hEDS.
Early diagnosis of joint hypermobility in children and adolescents is important because hypermobility has been associated with joint pain, altered joint proprioception, muscle weakness, and in some cases impaired motor development [5, 10, 11] . Pain may precipitate school avoidance behaviors and lead to decreased participation in other activities. However, the literature describing the treatment of chronic pain associated with JHS in pediatric patients is limited. A review of treatment of joint hypermobility in the pediatric population revealed 2 studies that evaluated the effectiveness of physical therapy for pain reduction in children with hypermobility. Both studies demonstrated that physical therapy decreased pain and increased function in the participants [2, 3] . The present study aimed to determine if pediatric patients with chronic pain related to JHS can be effectively treated with an interdisciplinary pain management program, as measured by changes in pain, psychosocial and physical functioning, and parental coping.
Methods

Design
This was a retrospective cohort study, approved by an institutional review board. The institution's electronic medical record was used to identify all pediatric patients with JHS treated in the intensive interdisciplinary pain management program from January 1, 2009, to November 1, 2015.
Participants
All patients 18 years of age and younger with joint hypermobility who were treated in the intensive interdisciplinary pain management program were eligible for inclusion. Our sample included patients ages 9-18. In describing these patients, we chose the word pediatric, which, according to the Academy of Pediatrics, defines individuals ages 1-21. Adolescent defines individuals 12-21 years old, and this does not include our entire sample.
Patients and parents were separately administered the Bath Adolescent Pain Questionnaire (BAPQ) (patients) or the Bath Adolescent Pain-Parent Impact Questionnaire (BAP-PIQ) (parents) at admission and discharge from the treatment program. They were instructed to complete the questionnaire independently, and did so under direct observation. Joint hypermobility was defined as clinical evidence of multijoint hypermobility as identified by the original Beighton score of greater than 4 [12] . The Beighton score is a 9-point scale used to measure joint hypermobility that involves performance of 4 passive bilateral maneuvers and 1 active unilateral maneuver. It has been shown to be a valid measure for generalized hypermobility in children [13] . The Beighton score has also demonstrated high interobserver (0.75) and intraobserver (0.78) kappa values for generalized joint laxity [14] . Patients who did not have both admission and discharge average numeric rating scale (NRS) pain ratings documented (primary outcome measure) were excluded from analysis.
Treatment Protocol
Although treatment of patients in an intensive interdisciplinary pain management program is individuated based on the needs of each patient, common features of our program included physical therapy, occupational therapy, psychology counseling, relaxation training, and medication management by a pediatric physiatrist. The program consisted of 1 to 2 half-day sessions per week (approximately 3-4 hours) for 4 to 8 weeks. Physical therapy emphasized improvement of joint stability, proprioception, muscle strength, and overall cardiovascular fitness, because patients tend to be sedentary as a result of pain. Occupational therapy focused on postural biomechanics, the safe completion of functional daily tasks, pacing, and development of a daily schedule. Psychological interventions included strategies to self-manage pain and stress, including relaxation techniques, and the use of coping self-statements to help in times of distress. Medication management often focused on correcting poor sleep latency and providing as-needed relief for breakthrough pain that did not respond to the above nonpharmacologic approaches.
At the start of the program, parents were asked to attend the initial treatment session, so that the therapists could discuss patient goals and treatment guidelines. The psychologist reviewed the concept of selfperpetuating cycles of pain with patients and parents. At this meeting, the various areas of treatment that the team targeted, including guarding, deconditioning, poor sleep hygiene and stress management, were reviewed. Parents were urged to avoid asking their child about the pain, and encouraged to focus instead on the child's functioning. During treatment, therapists met with parents to answer questions, assisted in problem solving, and provided coaching. Patients and parents were seen together, so that both could hear the information provided, and patients did not feel that conversations about them were occurring without their knowledge. The physician met with patients and their parents on a weekly basis to review program participation, provided ongoing medication management, and answered questions regarding medical concerns. Parents were asked to attend their child's discharge session to discuss gains made in the program and address issues related to relapse prevention.
Outcome Measures
Numeric Rating Scale
Changes in average/typical pain intensity ratings preand post-treatment were measured using an 11-point NRS ranging from 0 (no pain) to 10 (worst pain imaginable). The NRS is a validated and reliable measure of pain in the pediatric population [15] [16] [17] [18] [19] .
Bath Adolescent Pain questionnaire
The BAPQ is a 61-item instrument that consists of 7 subscales designed to assess the impact of chronic pain in patients ages 8-18 [20] . The subscales measure daily functioning (social and physical), emotional functioning (depression, general anxiety, and pain specific anxiety), family functioning, and developmental functioning. Items are answered using a 5-point frequency scale (0 = never to 4 = always) for all subscales, with the exception of developmental functioning, which uses a 5-point scale ranging from 0 (very behind) to 4 (very ahead) in response to various developmental tasks. Higher scores represent more impaired functioning on all subscales. The BAPQ is a valid and reliable measure of the impact of chronic pain on adolescents [20] .
Parent Bath Adolescent Pain-Parental Impact Questionnaire
The BAP-PIQ is a 62-item instrument with 8 subscales of functioning used to assess the impact of pediatric chronic pain on parents [21] . The 8 subscales measure parental emotional functioning (depression and anxiety), catastrophic thinking about one's child, self-blame and hopelessness, relationship with one's partner, leisure functioning, parental behavior, and parental strain. Responses for all 8 subscales are indicated using a 5-point frequency scale (0 = never to 4 = always), with more impaired function represented by higher subscale scores. The BAP-PIQ is a valid and reliable measure of parent functioning in those with adolescents who have chronic pain [21] .
Statistical analysis
All data were analyzed using PASW Statistics, version 18, IBM, Chicago, IL. Descriptive statistics were used to present demographic information. Prior to analyses, data were examined to ensure that statistical assumptions were met. A series of paired-samples t tests were used to examine treatment effects, that is, changes from pre-to posttreatment. A standardized measure of effect size, Cohen d, was reported to index the magnitude of the observed differences between pre-and post-treatment scores [22] . Effect sizes of 0.2, 0.5, and 0.8, regardless of sign, represent small, medium, and large effects [23] . The statistical significance level was set at P < .05 for all analyses. In addition to the analyses of statistical significance, both reliable change and clinically significant changes were assessed for the primary (patient) treatment group.
The Reliable Change Index (RCI) was used to determine the amount of change needed on each measure in order for the change to be considered a reliable change, or a change beyond what would be expected because of measurement error alone. As presented in the formula below, the SE of difference (S diff ) was calculated using the standard errors of measurements (SEMs) from the pre-and post-treatment scores [24] . Consistent with other studies assessing outcomes of interdisciplinary pain management, a 90% confidence interval (CI) was selected because of the nature of chronic pain and its associated symptoms as being unlikely to be eliminated or resolved [25] . The following formulas were used:
A threshold point for which a score needed to change in order to be considered clinically significant at discharge was calculated. Given the paucity of outcomes and normative data for the treatment population in the study, a balanced criterion was used in order to neither overestimate nor underestimate clinically significant change [26] . Furthermore, because of a lack of normative data for "normals" on the BAPQ scales, and considering that no other study has reported clinical significance for this measure, 1-month follow-up data from a study of pediatric pain patients who underwent a chronic pain rehabilitation program was used as the comparison group [27] . The following formula was used to calculate this cutoff criterion:
Results
Participants
Thirty patients were identified by chart review that met the inclusion criteria for the study. The majority (27; 90%) of the patients were female. The mean age was 14 years (SD = 2.84), ranging from 9 to 18 years. Primary diagnoses were EDS, hypermobility type (n = 16, 53.3%), and JHS (n = 14, 46.7%). The mean duration of pain was 3.26 years (SD = 3.51). The majority of BAP-PIQs were completed by the patient's mother (mother n = 29, 97%). In 4 cases, either pre-or post-treatment BAP-PIQs had not been completed; thus, the sample size for the parent outcomes was N = 26 (87%).
Treatment Outcomes (Patient)
Descriptive Statistics
Descriptive statistics of all treatment outcomes are shown in Table 1 .
Pain Intensity
The patients in the study reported a statistically significant reduction in average pain intensity ratings following treatment (t 29 = 2.203, P = .036, d = 0.40).
Daily Functioning
Following treatment, patients showed statistically significant improvements in their daily functioning, including both Social (t 29 = 2.914, P = .007, d = 0.54) and Physical (t 29 = 4.181, P < .001, d = 0.79) functioning as compared to their pretreatment reports. Chart review indicated that 29 of 30 patients (97%) returned to school. One patient had graduated and was no longer enrolled. The majority of patients returned to valued activities, including music, sports, theater, and crafting.
Emotional Functioning
Patients showed reductions in emotional distress from pre-to post-treatment. There was a statistically significant reduction in depression (t 29 = 2.194, P = .036, d = 0.51). Patients' reports of reduction in both general (t 29 = 2.632, P = .013, d = 0.45) and pain-related anxiety (t 29 = 4.132, P < .001, d = 0.78) also reached statistical significance.
Family Functioning
Post-treatment, there was a small reduction in the magnitude of impairment in family functioning reported by the patients. The reduction in family functioning impairment was not statistically significant (t 29 = 1.211, P = .236, d = 0.23).
Development
Following treatment, there was a reduction in how far behind the patients viewed themselves compared to their peers on several developmental tasks; however, this preto post-treatment reduction was not statistically significant (t 29 = 1.694, P = .101, d = 0.29).
Clinically Significant Change and Reliable Change
The RCIs and clinically significant change criteria along with the comparison group data are presented in Table 2 . As can be seen, the reliability coefficient for pain intensity is not included. To date, the only study examining the test-retest of the NRS with pediatric patients employed a statistical method (ie, the Bland-Altman method) that does not produce a reliability coefficient [18, 19, 28] . Therefore, the results for pain intensity are based solely on the clinically significant change criterion. The frequencies of which patients met reliability and clinical significance are presented in Table 3 . Among the 5 outcomes (emotional and daily functioning scales) that were statistically significant (excluding pain intensity due to lack of RCI data), on average 29.3% of the patients met the standards for both clinical and reliable improvement (range = 16.7%-36.7%). An additional 9.3% (average) were classified as either clinically or reliably changed (range = 0-16.7%), and an average of 9.9% (3.3%-13.3%) were reliably worse following treatment. A sizable proportion of patients (36.7%) had clinically significant reductions in pain intensity. Further exploration of the data showed that 70% of the patients had both clinically and reliably significant improvements in 1 or more of the 5 statistically significant BAPQ subscales, with 23.4% of the patients showing improvements in 3 or more of the subscales.
Treatment Outcomes (Parent)
Descriptive Statistics
Descriptive statistics of all treatment outcomes are shown in Table 4 .
Emotional Functioning
Following the treatment of their children, parents reported statistically significant reductions in emotional 
Parental Coping
Parents endorsed less catastrophic thinking about their children following the program as compared to pretreatment. This reduction in child-related catastrophizing was statistically significant (t 25 = 5.334, P < .001, d = 0.93). Also, the parents indicated a statistically significant reduction in the amount of self-blame and helplessness that they experienced post-treatment (t 25 = 6.761, P < .001, d = 1.08).
Relationship With One's Partner
Parents who were in a relationship (n = 19) reported a reduction in the amount of disruption perceived due to their child's pain; however, the pre-to post-treatment improvement was not statistically significant (t 18 = 1.793, P = .090, d = 0.25).
Leisure Functioning
Following their child's treatment, parents endorsed less disruption in their leisure activities as compared to their report of leisure disruption prior to their child's treatment; the improvement was statistically significant (t 25 = 3.099, P = .005, d = 0.64).
Parental Behavioral
Parents reported less frequent engagement in detrimental behaviors related to their child's pain (eg, allowing their child to avoid activities) post-treatment as compared to pre-treatment. The improvement in parental behavior was statistically significant (t 25 = 7.821, P < .001, d = 1.36).
Parental Strain
The reduction in pre-to post-treatment strain reported by parents was not statistically significant (t 25 = 1.171, P = .252, d = 0.17).
Additional Exploratory Analyses
Because of discrepancies in the literature regarding the phenotypic presentation of EDS vs JHS we examined group differences in the present data set (53% EDS and 47% JHS). One-way analyses of variance showed no group difference (EDS vs JHS) on any of the subscale scores of the BAPQ at pretreatment evaluation (all P's > .10). Descriptive data are shown in Table 5 . Examination of pre-to post-treatment score changes (Table 6 ) using 1-way analyses of variance showed similar improvements between the groups with no significant group differences in 7 of the 8 subscales (P values for nonsignificant results ≥.250). The one significant difference was in the Family functioning subscale where patients with EDS demonstrated improvement, whereas, as a group, those with JHS showed a decline in family functioning (P = .019). Baseline BAPQ subscale scores of the present study cohort were very similar to those previously reported by Eccleston and colleagues in treating pediatric patients with chronic pain, with the exception of the scores on the Development subscale, in which the present sample showed less impairment [20] . A comparison of the means and SD of the Development subscale scores between the 2 studies yielded a P value of .001, with the P values for the remaining subscales being greater than or equal to .668. In addition, baseline BAPO-PIQ subscale scores were all similar to those previously reported for parents of children with chronic pain seen in a pain management clinic [21] . P values for the 8 subscales were all greater than .05.
Discussion
Treating pain associated with JHS is challenging given the multidimensional nature of this disorder. The present study showed that an interdisciplinary pain management program that incorporates physical and occupational therapy, pain psychology, relaxation training, and medication management is associated with improvements in pain, physical and psychological functioning, and sequela that accompany juvenile JHS.
Previous studies have indicated that children diagnosed with JHS are at increased risk for developing chronic pain and reduced aerobic fitness, due to inactivity and deconditioning [4, 29, 30] . A high percentage of these patients reported problems in physical activities such as handwriting, participation in physical education, and consistent school attendance due to symptoms. Identifying those most at risk for such dysfunction can facilitate planning for effective early interventions, including interdisciplinary rehabilitation, which should include both psychological and physical treatment components. Interventions include identifying and changing catastrophizing thoughts and maladaptive behavioral practices. Cognitive behavioral strategies, including the use of coping self-statements and relaxation training, were designed to facilitate improved pain coping. Postural retraining, body mechanics education, pacing strategies, and graded return to cardiovascular exercise were targeted to improve physical functioning.
The results of this study indicate that the average pain intensity rating as well as multiple domains of patient and parent functioning improved significantly from pre-to post-treatment, with effect sizes ranging from 0.40 to 1.36. Furthermore, more than two-thirds of the JHS patients showed improvement on least 1 outcome that met criteria for reliable and clinical improvement. Reduction in pain intensity, with nearly 40% of the patients showing clinically significant reductions is particularly noteworthy, given that the mean duration for pain in these participants was over 3 years. These results demonstrate that interdisciplinary treatment can provide both the physical tools and the education necessary to facilitate pain management, even in those patients who experience years of chronic pain.
Participants also demonstrated improved physical and social functioning that was not only statistically significant but reliably and clinically significantly improved. The program focused on return to valued activities, even if some pain persists. Pediatric patients responded to interventions to improve physical fitness and increase daily exercise by not only demonstrating increased physical independence but also engaging in more active social relationships. An important element of the program is teaching pediatric patients with JHS pacing techniques to facilitate improved engagement in social interactions, as well as helping them address questions that others may have about their diagnosis and physical limitations. As participants increased their physical activity and learned pain management tools, they may have been able to understand that pain did not have to be feared or avoided, but could be controlled. This understanding likely promoted increased activity and also may have led to reductions in both anxiety and depression. One unexpected result was the fact that although EDS patients rated their family function as improved posttreatment, JHS patients reported a decline in family functioning. Further research is needed to determine if this finding is consistent with another sample of JHS patients. In some families, positive changes in even 1 member's functioning can alter family dynamics and result in overall negative changes in family dynamics. Why this would occur for JHS patients but not for those with EDS is difficult to explain at this point.
As with patient function, parent coping improved significantly from pre-to post-program. A child's pain can have a tremendous impact on the functioning of the parent, particularly as it relates to the parent's distress. In turn, parental distress can impact the child's ability to cope with the pain [21] . By providing counseling and information to parents as part of the interdisciplinary pain program, attempts were made to break that cycle, and to improve both patient and parent functioning. The program addressed catastrophizing thoughts and promoted a realistic understanding of the participants' abilities and limitations. Parents were provided with education about pain-coping tools and were encouraged to serve as coaches, responding to the pain with problem solving strategies, rather than attention to avoidant and dysfunctional behaviors. The present data suggest that parental depression, anxiety, catastrophizing, and detrimental behaviors decreased as a result of these interventions. Consequently, parents also reported fewer disruptions to their own leisure activities. Any study examining the impact of treatment on the pediatric patient should ideally also evaluate the impact of that treatment on parents, keeping in mind the reciprocal relationship of the two [21] . Helping parents understand how to cope with their child's pain while setting limits provides an important structure for the recovery process for both patients and parents.
This study adds to the limited literature available describing the treatment of pain associated with JHS. Reductions in pain were noted in 2 previous studies that employed physical therapy to address joint pain and instability in pediatric patients [2, 3] . The present study enhances those findings and highlights the importance of interdisciplinary treatment that addressed not only joint pain but impairments in physical and social functioning and parental response to pain. Pediatric patients with JHS benefit from a team approach to pain management that emphasizes coping with the fear of pain and provides support and education to parents as well as patients.
Limitations
Limitations of the present study include the retrospective design, the lack of "normal" normative outcome data, and the evaluation of the impact of length of stay (LOS). There are a number of reasons why we did not evaluate improvement based on LOS. These include the fact that patients were not randomly assigned to LOS conditions, that LOS was influenced by a number of potential confounding factors, including insurance coverage, feasibility, and patient availability. Further, with a total patient population of 30, dividing groups into LOS cohorts would lead to sample sizes too small for significant comparison. In the future, the relationship of LOS to improvement could be explored with a larger sample size and control of confounding factors. There is a need to incorporate new, proposed changes to the classification of Ehlers-Danlos Syndromes. Specifically, future studies should use the new, proposed Malfait criteria to better differentiate those patients with hEDS from those with hypermobility spectrum disorder [8] . A larger prospective study with control for LOS, use of the new classification system, and longer-term follow-up is needed to validate the present results. Gains made in an interdisciplinary program should be tracked for 1 year. For patients, school attendance and participation in after-school activities and sports should be monitored, as these activities provide information about the effective use of pain management tools. For parents, the amount of time spent with the patient in medical visits, as well as time spent addressing pain issues, are worthy of examination.
Conclusion
This study demonstrates that an interdisciplinary rehabilitation program designed to treat pediatric patients with JHS can provide improvements in pain and physical functioning, as well as emotional functioning for both patients and parents. These changes highlight the importance of addressing both physical and psychological components associated with dysfunction related to JHS in order to produce lasting improvements for both the patient and the parent.
